“…Reactions that form challenging C–X bonds, including C–N, C–F, C–O, and C–CF 3 , are critically important for the discovery and design of drug-related molecules. , These coupling reactions have long relied on the judicious design of ligands that accelerate rates of reductive elimination from organometallic intermediates. − Recent approaches leverage the reactivity of high-valent organometallic complexes bearing inexpensive ligands to effect similar reactions. − However, accessing these high-valent organometallic complexes typically requires oxidation with superstoichiometric quantities of peroxides, , N -fluoropyridiniums, ,− xenon difluoride, , silver salts, hypervalent iodide, or pressurized oxygen. , Efforts to mitigate the hazards and wastes associated with strong chemical oxidants have focused on new strategies for electron transfer (ET) and oxidation, including photoredox catalysis − and electrosynthesis. − Electrochemistry is particularly well-suited for net oxidative (or reductive) organic transformations because reactions can be designed for the anode while providing a benign reagent, like a proton, for consumption at the opposite electrode. In doing so, electrical energy and a proton can replace energetic chemical oxidants …”